Kristin Stephens - Chief Development Officer at Syros Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Development Officer
Stock Symbol
SYRS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kristin Stephens since 10/5/2023

Holdings reported by Kristin Stephens for Syros Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 25.2K $129K $5.12 Apr 1, 2024 Direct
Restricted Stock Units 23.3K $116K $4.98 Mar 31, 2024 Direct Common Stock

Transactions reported by Kristin Stephens for Syros Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.